We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+3.98%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$29.9B
AUM Growth
+$1.03B
Cap. Flow
+$181M
Cap. Flow %
0.61%
Top 10 Hldgs %
19.41%
Holding
1,859
New
106
Increased
777
Reduced
753
Closed
113

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$174M
2
DOC icon
Healthpeak Properties
DOC
+$98.8M
3
WMB icon
Williams Companies
WMB
+$71.3M
4
AMZN icon
Amazon
AMZN
+$61.5M
5
VTR icon
Ventas
VTR
+$61.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.15%
2 Consumer Staples 12.29%
3 Energy 10.19%
4 Financials 9.17%
5 Industrials 8.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRUS icon
1026
Cirrus Logic
CRUS
$5.91B
$1.59M 0.01%
79,906
+17,826
+29% +$339K
CMC icon
1027
Commercial Metals
CMC
$7.28B
$1.59M 0.01%
84,040
+6,759
+9% +$131K
PAG icon
1028
Penske Automotive Group
PAG
$14.1B
$1.59M 0.01%
37,082
+266
+0.7% +$11.6K
HRC
1029
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$1.58M 0.01%
40,934
+2,704
+7% +$104K
NEE icon
1030
NextEra Energy
NEE
$168B
$1.57M 0.01%
65,688
+56
+0.1% +$1.27K
WEN icon
1031
Wendy's
WEN
$1.34B
$1.57M 0.01%
172,058
+46,203
+37% +$423K
GG
1032
DELISTED
Goldcorp Inc
GG
$1.57M 0.01%
64,100
-14,065
-18% -$358K
GCO icon
1033
Genesco
GCO
$361M
$1.57M 0.01%
21,001
-978
-4% -$71K
MYGN icon
1034
Myriad Genetics
MYGN
$369M
$1.56M 0.01%
45,674
+7
+0% +$217
HY icon
1035
Hyster-Yale Materials Handling
HY
$601M
$1.56M 0.01%
16,001
+5,696
+55% +$535K
RVNC
1036
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.56M 0.01%
+49,490
New +$1.55M
CRTO icon
1037
Criteo S.A.
CRTO
$838M
$1.56M 0.01%
38,429
+17,000
+79% +$704K
MTX icon
1038
Minerals Technologies
MTX
$2.15B
$1.55M 0.01%
24,047
+46
+0.2% +$2.6K
AZPN
1039
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$1.55M 0.01%
36,598
+7,201
+24% +$305K
MRC
1040
DELISTED
MRC Global
MRC
$1.54M 0.01%
57,254
-1,570,913
-96% -$43.9M
RFMD
1041
DELISTED
RF MICRO DEVICES INC
RFMD
$1.54M 0.01%
195,880
-6,960,104
-97% -$42.8M
CVG
1042
DELISTED
Convergys
CVG
$1.54M 0.01%
70,370
+5,706
+9% +$118K
JNS
1043
DELISTED
Janus Capital Group Inc
JNS
$1.54M 0.01%
141,422
-32,726
-19% -$370K
CEB
1044
DELISTED
CEB Inc.
CEB
$1.53M 0.01%
20,564
-7,870
-28% -$590K
IDCC icon
1045
InterDigital
IDCC
$8.48B
$1.52M 0.01%
45,984
+30,974
+206% +$922K
FAF icon
1046
First American
FAF
$7.26B
$1.52M 0.01%
57,323
-32,482
-36% -$862K
PRAA icon
1047
PRA Group
PRAA
$756M
$1.52M 0.01%
26,267
-13,521
-34% -$726K
GATX icon
1048
GATX Corp
GATX
$6.27B
$1.51M 0.01%
22,274
-6,000
-21% -$361K
ACIW icon
1049
ACI Worldwide
ACIW
$5.21B
$1.51M 0.01%
76,542
-3,153
-4% -$63.8K
CYTK icon
1050
Cytokinetics
CYTK
$9.65B
$1.5M 0.01%
+158,400
New +$1.43M

Similar funds

Federated Hermes's Q1 2014 Portfolio in Review

As of Q1 2014, Federated Hermes held 1,859 positions worth $29.9B, up 3.6% from $28.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Federated Hermes's Q1 2014 filing shows 106 new, 777 increased, 753 reduced and 113 closed positions. Its largest new stake was Colony Capital, Inc.: 1,465,448 shares worth $32.2M. The largest sale was AbbVie, an estimated $210M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Energy.

  • Federated Hermes's largest Q1 2014 buy was Colony Capital, Inc.: 1,465,448 shares worth $32.2M.
  • Federated Hermes added most to Philip Morris in Q1 2014, an estimated $174M increase.
  • Federated Hermes's biggest Q1 2014 reduction was AbbVie, cutting an estimated $210M.
  • Federated Hermes fully exited Sinclair Inc in Q1 2014, selling an estimated $36.1M.
  • Federated Hermes's ten largest holdings make up 19% of its $29.9B portfolio in Q1 2014.
  • Federated Hermes opened 106 new positions and closed 113 in Q1 2014.
  • Federated Hermes's portfolio value rose 3.6% quarter-over-quarter to $29.9B.

Based on Federated Hermes's 13F filing for Q1 2014, filed 6 May 2014.